EE WAN: Open Payments
NPI 1558532317 · MEDFORD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$880 in 36 payments from 14 companies in 2025. Trend: 2023 $538 · 2024 $655 · 2025 $880
Food & beverage: $880
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $254 |
| AstraZeneca Pharmaceuticals LP | 8 | $140 |
| Lilly USA, LLC | 5 | $113 |
| Otsuka America Pharmaceutical, Inc. | 5 | $97 |
| Corcept Therapeutics | 3 | $67 |
| Madrigal Pharmaceuticals | 1 | $29 |
| Boston Scientific Corporation | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $25 |
Products named: Wegovy, REXULTI, Ozempic, AIRSUPRA, Korlym, ZEPBOUND, FARXIGA, MOUNJARO.
Industry payments across OR — which companies pay providers there.
